NCT00063622View on ClinicalTrials.gov

Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)

PHASE3CompletedINTERVENTIONAL
Enrollment

247

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

September 30, 2009

Conditions
Liver Diseases
Interventions
DRUG

Pioglitazone

30 mg daily

DIETARY_SUPPLEMENT

Vitamin E

800 IU daily

DRUG

Matching placebo

Daily

Trial Locations (8)

23298

Virginia Commonwealth University, Richmond

27710

Duke University Medical Center, Durham

44109

Case Western Reserve University, Cleveland

46202

Indiana University, Indianapolis

63110

St. Louis University, St Louis

92103

University of California, San Diego, San Diego

94143

University of California, San Francisco, San Francisco

98195

University of Washington, Seattle

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00063622 - Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) | Biotech Hunter | Biotech Hunter